C0599949||Arterial Stiffness
C0005767||Blood
C0011860||Type 2 diabetes
C0042373||macrovascular
C0042373||microvascular impairments
C0005847||Vascular
C0599949||arterial stiffness
C0599949||arterial stiffness
C0014257||endothelial
C0007222||cardiovascular disease
C3494430||Pulse wave analysis
C3494430||Pulse wave analysis
C0599949||arterial stiffness
C3887610||disease states
C0242656||progression
C0005767||blood
C1283169||monitoring
C0011847||diabetes
C0243095||expensive
C0599949||arterial stiffness
C0430027||biochemical tests
C0242656||disease progression
C0011860||type 2 diabetes mellitus
C0936012||analyzed
C0005767||blood
C0599949||arterial stiffness
C0424679||fat-free mass
C3494430||Pulse wave analysis
C0299583||Leptin
C0006560||C-reactive protein
C3494430||Pulse wave analysis
C0022885||Body composition methods
C0011860||type 2 diabetes mellitus
C0042373||vascular disease
C0242656||progression
C2603343||study
C1285593||body composition measurements
C0022885||expensive tests
C0699943||public health
C3494318||health surveillance
C0454664||countries
C0549106||financial challenges